Combination therapy of adalimumab with an immunomodulator is not more effective than adalimumab monotherapy in children with crohn's disease: A post Hoc analysis of the PAILOT randomized controlled trial

Manar Matar, Raanan Shamir, Dan Turner, Efrat Broide, Batia Weiss, Oren Ledder, Anat Guz-Mark, Firas Rinawi, Shlomi Cohen, Chani Topf-Olivestone, Ron Shaoul, Baruch Yerushalmi, Shomron Ben-Horin, Amit Assa

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Combination therapy of adalimumab with an immunomodulator is not more effective than adalimumab monotherapy in children with crohn's disease: A post Hoc analysis of the PAILOT randomized controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences